Columbus Circle Investors’s Labcorp LH Stock Holding History

Columbus Circle Investors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,947	Closed	-$2.07M	–	224
2017 Q3	$2.07M	Buy	+15,947	New	+$2.13M	0.04%	221

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Columbus Circle Investors's LH Position: Q4 2017 in Review

Columbus Circle Investors sold out of Labcorp (LH) in Q4 2017, closing a stake of 18,513 shares — an estimated $2.4M sold.

Columbus Circle Investors first reported a position in LH in Q2 2016 and held it in 6 quarters. The position peaked at $30.3M in Q3 2016. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

Columbus Circle Investors reported no remaining Labcorp position as of Q4 2017 after selling out during the quarter.
Columbus Circle Investors sold 18,513 Labcorp shares in Q4 2017, an estimated $2.4M.
Columbus Circle Investors first reported a position in Labcorp in Q2 2016 and held it in 6 quarters.
Columbus Circle Investors's Labcorp position peaked at $30.3M in Q3 2016.
753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.